Intestinal Cancer in Celiac Disease

Daniel G Sur¹, Borodi Mihaela¹, Emanuela Floca¹ and Genel Sur^{1, 2,}

¹Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

²Emergency Hospital for Children, Cluj-Napoca, Romania

Cite this paper:
Daniel G Sur, Borodi Mihaela, Emanuela Floca and Genel Sur. Intestinal Cancer in Celiac Disease. International Journal of Celiac Disease. 2017; 5(1):28-29. doi: 10.12691/ijcd-5-1-9

Abstract

Celiac disease is an autoimmune disease caused by gluten in genetically predisposed persons. The prevalence of the disease in is about 1%. Early diagnosis of celiac disease is important because it allows the onset of gluten free diet that will prevent the occurrence of gastrointestinal cancers. Considering that the symptoms of the disease do not always include typical manifestations, diagnosis may not always be easily supported. This disease can evolve in various forms - masks of celiac disease - including: classic form, non-classical, subclinical and potential form. The risk of complications, especially cancer, increases with delay in diagnosis.

Keywords:
celiac disease intestinal cancer malignancy

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	West J, Logan R, Smith CJ et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329:716.
[2]	Freeman HJ. Adult celiac disease and its malignant complications. Gut and Liver 2009;3:237-246.
[3]	van den Brandt PA, Goldbohm RA. Nutrition in the prevention of gastrointestinal cancer. Best Pract Res Clin Gastroenterol. 2006;20:589-603.
[4]	Turner ND, Lloyd SK. Association between red meat consumption and colon cancer: A systematic review of experimental results. Exp Biol Med. 2017; 0:1-27.
[5]	Sur G, Floca E, Sur L, Sur D, Samasca G. Clinical presentation of celiac disease masks. Therapeutic perspectives of celiac disease. Pharmaceut Anal Acta. 2013;4:1000228.
[6]	Elfström P, Granath F, Ekström Smedby Ket al. Risk of Lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011;103:436-444.
[7]	Catassi C, Bearzi I, Holmes G. Association of celiac disease and intestinal lymphomas and other cancers. 2005;128:S79-S86.
[8]	Gao Y, Kristinsson S, Goldin L et al. Increased Risk for Non-Hodgkin Lymphoma in Individuals With Celiac Disease and a Potential Familial Association. Gastroenterol. 2009;136:91-98.
[9]	Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES: The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011; 117:5019-5032.
[10]	Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpe- tiformis: 30-year population-based study. Dig Liver Dis 2006; 38:374-380.
[11]	Samasca G, Sur G, Lupan I. Current Trends and Investigative Developments in Celiac Disease. Immunological Investigations. 2013; 42: 273-284.
[12]	Matysiak-Budnik T, Malamut G, de Serre NP, et al. Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007;56:1379-1386.